| A bromoenol lactone suicide substrate inactivates group VIA phospholipase A2 by generating a diffusible bromomethyl keto acid that alkylates cysteine thiols. | |
| | |
MedLine Citation:
|
PMID: 16411783 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Phospholipases A2 (PLA2) comprise a superfamily of enzymes that hydrolyze phospholipids to a free fatty acid, e.g., arachidonate, and a 2-lysophospholipid. Dissecting their individual functions has relied in large part on pharmacological inhibitors that discriminate among PLA2. Group VIA PLA2 (iPLA2beta) has a GTSTG serine lipase consensus sequence, and studies with a bromoenol lactone (BEL) suicide substrate inhibitor have been taken to suggest that iPLA2beta participates in a wide variety of biological processes. Such conclusions presume inhibitor specificity. Inhibition by BEL requires its hydrolysis by and results in uncharacterized covalent modification(s) of iPLA2beta. We performed mass spectrometric analyses of proteolytic digests of BEL-treated iPLA2beta to identify modifications associated with loss of activity. The GTSTG active site and large flanking regions of sequence are not modified by BEL treatment, but most iPLA2beta Cys residues are alkylated at various BEL concentrations to form a thioether linkage to a BEL keto acid hydrolysis product. Synthetic Cys-containing peptides are alkylated when incubated with iPLA2beta and BEL, which reflects iPLA2beta-catalyzed BEL hydrolysis to a diffusible bromomethyl keto acid product that reacts with distant thiols. The BEL concentration dependence of Cys651 alkylation closely parallels that of loss of iPLA2beta activity. No amino acid residues other than Cys were found to be modified, suggesting that Cys alkylation is the covalent modification of iPLA2beta responsible for loss of activity, and the alkylating species appears to be a diffusible hydrolysis product of BEL rather than a tethered acyl-enzyme intermediate. |
| | |
Authors:
|
Haowei Song; Sasanka Ramanadham; Shunzhong Bao; Fong-Fu Hsu; John Turk |
Related Documents
:
|
1452293 - Molecular determinants of human prorenin processing. 838473 - Snake venom toxin. the amino acid sequence of three toxins (cm-2h, cm-4b and cm-6) from... 12912963 - Tannic acid is an inhibitor of cxcl12 (sdf-1alpha)/cxcr4 with antiangiogenic activity. |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Extramural |
Journal Detail:
|
Title: Biochemistry Volume: 45 ISSN: 0006-2960 ISO Abbreviation: Biochemistry Publication Date: 2006 Jan |
Date Detail:
|
Created Date: 2006-01-17 Completed Date: 2006-04-17 Revised Date: 2011-09-26 |
Medline Journal Info:
|
Nlm Unique ID: 0370623 Medline TA: Biochemistry Country: United States |
Other Details:
|
Languages: eng Pagination: 1061-73 Citation Subset: IM |
Affiliation:
|
Medicine Department Mass Spectrometry Facility, Division of Endocrinology, Metabolism, and Lipid Research, Washington University School of Medicine, St. Louis, Missouri 63110, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Amino Acid Sequence Baculoviridae / genetics Cells, Cultured Cysteine / chemistry* Diffusion Enzyme Inhibitors / chemistry, pharmacology* Group II Phospholipases A2 Hydrocarbons, Brominated / chemistry* Keto Acids / chemistry* Models, Molecular Molecular Sequence Data Naphthalenes / metabolism* Phospholipases A / antagonists & inhibitors*, chemistry, genetics, metabolism Phospholipases A2 Pyrones / metabolism* Recombinant Proteins / metabolism Substrate Specificity Sulfhydryl Compounds / metabolism* |
| Grant Support | |
ID/Acronym/Agency:
|
P01-HL57278/HL/NHLBI NIH HHS; P30 DK056341-05S2/DK/NIDDK NIH HHS; P30 DK056341-06/DK/NIDDK NIH HHS; P30 DK056341-069003/DK/NIDDK NIH HHS; P30-DK56341/DK/NIDDK NIH HHS; P41 RR000954-30/RR/NCRR NIH HHS; P41-RR00954/RR/NCRR NIH HHS; P60 DK020579-269005/DK/NIDDK NIH HHS; P60-DK20579/DK/NIDDK NIH HHS; R01-69455//PHS HHS; R37 DK034388-23/DK/NIDDK NIH HHS; R37-DK34388/DK/NIDDK NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Enzyme Inhibitors; 0/Hydrocarbons, Brominated; 0/Keto Acids; 0/Naphthalenes; 0/Pyrones; 0/Recombinant Proteins; 0/Sulfhydryl Compounds; 52-90-4/Cysteine; 74-83-9/methyl bromide; 88070-98-8/6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2H-pyran-2-one; EC 3.1.1.-/Phospholipases A; EC 3.1.1.4/Group II Phospholipases A2; EC 3.1.1.4/Phospholipases A2 |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: A laser flash-induced kinetic analysis of in vivo photosystem I reduction by site-directed mutants o...
Next Document: A pilot study: the effects of music therapy interventions on middle school students' ESL skills.